Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 23;99(43):e22840.
doi: 10.1097/MD.0000000000022840.

Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations

Gao Song  1 , Meng Qun Cheng  2 , Xian Wen Wei  3
Affiliations

Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations

Gao Song et al. Medicine (Baltimore). .

Abstract

Up-to-date information on the current progress made in the research and development to control the global COVID-19 pandemic is important. The study aimed to analyze the clinical trial characteristics and vaccine development progress of the new Coronavirus Disease 2019 (COVID-19) registered with the World Health Organization International Clinical Trial Registry Platform (WHO ICTRP).A comprehensive search of COVID-19 clinical trials since the establishment of the ICTRP to June 11, 2020, was conducted to record and analyze relevant characteristics. Chi-Squared test was used to compare the statistical differences between different research types, interventions, and sources.A total of 3282 COVID-19 clinical trials in 17 clinical trial registration centers were registered with the WHO ICTRP. The main research sources for the present study were ClinicalTrials.gov and ChiCTR. There were significant differences in the parameters of study location (P = .000), number of participants (P = .000), study duration (P = .001), research stage (P = .000), randomization procedure (P = .000), and blinding method (P = .000) between the 2 registration sources. There were significant differences in all the parameters between different kinds of intervention methods. Hydroxychloroquine, plasma therapy, and Xiyanping injection were the high-frequency research drugs used. Ten different vaccine studies were registered under phases I-II.Amongst the studies researched, heterogeneity existed for various parameters. Differences in the type of study, interventions, and registration sources of the studies led to significant differences in certain parameters of the COVID-19 clinical trials. The statistics of high-frequency drugs and the progress of vaccine trials may provide an informative reference for the prevention and control of COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Wu T, Perrings C, Kinzig A, et al. Economic growth, urbanization, globalization, and the risks of emerging infectious diseases in China: a review. Ambio 2017;46:18–29. - PMC - PubMed
    1. Xu Yi. Several emergency and re-emerging infectious diseases. Chinese J of Pra Ped 2018;33:426–30.
    1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome- related coronavirus: classifying 2019- nCoV and naming it SARS- CoV-2. Nat Microbiol 2020;5:536–44. - PMC - PubMed
    1. Lupia T, Scabini S, Mornese Pinna S, et al. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist 2020;21:22–27. - PMC - PubMed
    1. Smith JA, Judd J. COVID-19: Vulnerability and the power of privilege in a pandemic. Health Promot J Aust 2020;31:158–160. - PMC - PubMed